Tizona Lands AbbVie Cancer R&D Deal As New CEO Takes Control

 
• By Sten Stovall
ScienceLab
Tizona and AbbVie hope to develop and commercialize CD39-targeted therapeutics • Source: Shutterstock

More from Business

More from Scrip